trending Market Intelligence /marketintelligence/en/news-insights/trending/OHEE-w6TR5ywsd3BIiWNmg2 content esgSubNav
In This List

Sawai closes acquisition of Upsher-Smith's generics biz

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy

Blog

Commercial Banking Newsletter June Edition - 2022


Sawai closes acquisition of Upsher-Smith's generics biz

Sawai Pharmaceutical Co. Ltd. completed its acquisition of Upsher-Smith Laboratories Inc.'s generic pharmaceuticals business.

The Japanese drugmaker plans to retain operations in Minnesota and Colorado.

Upsher-Smith's current president, Rusty Field, will take on the additional role of CEO.

Torreya Partners LLC and SMBC Nikko Securities Inc. acted as financial advisers to Sawai for the transaction, while Debevoise & Plimpton LLP acted as legal counsel. Upsher-Smith's financial advisers were J.P. Morgan Securities LLC and BMO Capital Markets, while Lindquist & Vennum LLP served as legal counsel.